{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:03:57Z","timestamp":1785877437634,"version":"3.56.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum des Saarlandes und Medizinische Fakult\u00e4t der Universit\u00e4t des Saarlandes"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mechanical thrombectomy has been shown to reduce thrombus burden and pulmonary artery pressure (PAP) and to improve right ventricular (RV) function in patients with high-risk or intermediate-high-risk pulmonary embolism (PE). As hemodynamic data after mechanical thrombectomy for PE are scarce, we aimed to assess the hemodynamic effects of mechanical thrombectomy in acute PE with right heart overload.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this prospective, open-label study, patients with acute symptomatic, computed tomography-documented PE with signs of right heart overload underwent mechanical thrombectomy using the FlowTriever System. Right heart catheterization was performed immediately before and after thrombectomy and after three months. Transthoracic echocardiography was performed before thrombectomy, discharge, and at three months. This analysis was done after 20 patients completed three months of follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Twenty-nine patients (34% female) underwent mechanical thrombectomy, of which 20 completed three months follow-up with right heart catheterization. Most patients were at high (17%) or intermediate-high (76%) risk and had bilateral PE (79%). Before thrombectomy, systolic PAP (sPAP) was severely elevated (mean 51.3\u2009\u00b1\u200911.6 mmHg). Mean sPAP dropped by -15.0 mmHg (95% confidence interval [CI]: -18.9 to -11.0; p\u2009&lt;\u20090.001) immediately after the procedure and continued to decrease from post-thrombectomy to three months (-6.4 mmHg, 95% CI: -10-0 to -2.9; p\u2009=\u20090.002). RV\/left ventricular (LV) ratio immediately reduced within two days by -0.37 (95% CI: -0.47 to -0.27; p\u2009&lt;\u20090.001). The proportion of patients with a tricuspid annular plane systolic excursion (TAPSE)\/sPAP ratio\u2009&lt;\u20090.31\u00a0mm\/mmHg decreased from 28% at baseline to 0% before discharge and at three months (p\u2009=\u20090.007). There were no procedure-related major adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Mechanical thrombectomy for acute PE was safe and immediately reduced PAP and improved right heart function. The reduction in PAP was maintained at three months follow-up.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-023-02552-w","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T20:34:37Z","timestamp":1698266077000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Mechanical thrombectomy in intermediate- and high-risk acute pulmonary embolism: hemodynamic outcomes at three months"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1434-9556","authenticated-orcid":false,"given":"Lucas","family":"Lauder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"P\u00e9rez Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"G\u00f6tzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Ewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussam","family":"Al Ghorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Haring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp M.","family":"Lepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saarraaken","family":"Kulenthiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Scheller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Mahfoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,25]]},"reference":[{"issue":"2","key":"2552_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jacc.2015.10.060","volume":"67","author":"D Jimenez","year":"2016","unstructured":"Jimenez D, de Miguel-Diez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R, et al. Trends in the management and outcomes of Acute Pulmonary Embolism: analysis from the RIETE Registry. J Am Coll Cardiol. 2016;67(2):162\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"2552_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ijcard.2018.07.059","volume":"269","author":"D Jimenez","year":"2018","unstructured":"Jimenez D, Bikdeli B, Barrios D, Quezada A, Del Toro J, Vidal G, et al. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism. Int J Cardiol. 2018;269:327\u201333.","journal-title":"Int J Cardiol"},{"issue":"4","key":"2552_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","volume":"41","author":"SV Konstantinides","year":"2020","unstructured":"Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing GJ, Harjola VP, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the european respiratory society (ERS). Eur Heart J. 2020;41(4):543\u2013603.","journal-title":"Eur Heart J"},{"issue":"10","key":"2552_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/eurheartj\/ehu218","volume":"36","author":"C Marti","year":"2015","unstructured":"Marti C, John G, Konstantinides S, Combescure C, Sanchez O, Lankeit M, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605\u201314.","journal-title":"Eur Heart J"},{"issue":"1","key":"2552_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0036-1597560","volume":"38","author":"SV Konstantinides","year":"2017","unstructured":"Konstantinides SV, Barco S. Systemic thrombolytic therapy for Acute Pulmonary Embolism: who is a candidate? Semin Respir Crit Care Med. 2017;38(1):56\u201365.","journal-title":"Semin Respir Crit Care Med"},{"issue":"4","key":"2552_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1093\/eurheartj\/ehz236","volume":"41","author":"K Keller","year":"2020","unstructured":"Keller K, Hobohm L, Ebner M, Kresoja KP, Munzel T, Konstantinides SV, et al. Trends in thrombolytic treatment and outcomes of acute pulmonary embolism in Germany. Eur Heart J. 2020;41(4):522\u20139.","journal-title":"Eur Heart J"},{"key":"2552_CR7","doi-asserted-by":"crossref","unstructured":"Gotzinger F, Lauder L, Sharp ASP, Lang IM, Rosenkranz S, Konstantinides S et al. Interventional therapies for pulmonary embolism. Nat Rev Cardiol. 2023:1\u201315.","DOI":"10.1038\/s41569-023-00876-0"},{"issue":"20","key":"2552_CR8","doi-asserted-by":"publisher","first-page":"e774","DOI":"10.1161\/CIR.0000000000000707","volume":"140","author":"J Giri","year":"2019","unstructured":"Giri J, Sista AK, Weinberg I, Kearon C, Kumbhani DJ, Desai ND, et al. Interventional therapies for Acute Pulmonary Embolism: current status and principles for the development of Novel evidence: a Scientific Statement from the American Heart Association. Circulation. 2019;140(20):e774\u2013e801.","journal-title":"Circulation"},{"issue":"6","key":"2552_CR9","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1016\/j.chest.2021.07.056","volume":"160","author":"SM Stevens","year":"2021","unstructured":"Stevens SM, Woller SC, Baumann Kreuziger L, Bounameaux H, Doerschug K, Geersing GJ, et al. Executive Summary: antithrombotic therapy for VTE Disease: second update of the CHEST Guideline and Expert Panel Report. Chest. 2021;160(6):2247\u201359.","journal-title":"Chest"},{"issue":"8","key":"2552_CR10","doi-asserted-by":"publisher","first-page":"e623","DOI":"10.4244\/EIJ-D-22-00246","volume":"18","author":"P Pruszczyk","year":"2022","unstructured":"Pruszczyk P, Klok FA, Kucher N, Roik M, Meneveau N, Sharp ASP, et al. Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary circulation and right ventricular function and the European Association of Percutaneous Cardiovascular Interventions. EuroIntervention. 2022;18(8):e623\u2013e38.","journal-title":"EuroIntervention"},{"issue":"9","key":"2552_CR11","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jcin.2018.12.022","volume":"12","author":"T Tu","year":"2019","unstructured":"Tu T, Toma C, Tapson VF, Adams C, Jaber WA, Silver M, et al. A prospective, Single-Arm, Multicenter Trial of Catheter-Directed Mechanical Thrombectomy for Intermediate-Risk Acute Pulmonary Embolism: the FLARE Study. JACC Cardiovasc Interv. 2019;12(9):859\u201369.","journal-title":"JACC Cardiovasc Interv"},{"key":"2552_CR12","doi-asserted-by":"crossref","unstructured":"Toma C, Jaber WA, Weinberg MD, Bunte MC, Khandhar S, Stegman B et al. Acute outcomes for the full US cohort of the FLASH mechanical thrombectomy registry in pulmonary embolism. EuroIntervention. 2022.","DOI":"10.4244\/EIJ-D-22-00732"},{"issue":"8","key":"2552_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1164\/rccm.200506-862OC","volume":"172","author":"D Aujesky","year":"2005","unstructured":"Aujesky D, Obrosky DS, Stone RA, Auble TE, Perrier A, Cornuz J, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172(8):1041\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"2552_CR14","doi-asserted-by":"publisher","first-page":"e009047","DOI":"10.1161\/CIRCIMAGING.119.009047","volume":"12","author":"K Tello","year":"2019","unstructured":"Tello K, Wan J, Dalmer A, Vanderpool R, Ghofrani HA, Naeije R, et al. Validation of the tricuspid annular plane systolic Excursion\/Systolic pulmonary artery pressure ratio for the Assessment of right ventricular-arterial coupling in severe pulmonary hypertension. Circ Cardiovasc Imaging. 2019;12(9):e009047.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2552_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2147\/COPD.S29571","volume":"7","author":"A Hareendran","year":"2012","unstructured":"Hareendran A, Leidy NK, Monz BU, Winnette R, Becker K, Mahler DA. Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:345\u201355.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"3","key":"2552_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/eurheartj\/ehab816","volume":"43","author":"FA Klok","year":"2022","unstructured":"Klok FA, Ageno W, Ay C, Back M, Barco S, Bertoletti L, et al. Optimal follow-up after acute pulmonary embolism: a position paper of the European Society of Cardiology Working Group on Pulmonary circulation and right ventricular function, in collaboration with the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology, endorsed by the european respiratory society. Eur Heart J. 2022;43(3):183\u20139.","journal-title":"Eur Heart J"},{"issue":"1","key":"2552_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1378\/chest.99.1.112","volume":"99","author":"R Cooper","year":"1991","unstructured":"Cooper R, Ghali J, Simmons BE, Castaner A. Elevated pulmonary artery pressure. An independent predictor of mortality. Chest. 1991;99(1):112\u201320.","journal-title":"Chest"},{"issue":"4","key":"2552_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1086\/674756","volume":"3","author":"GA Heresi","year":"2013","unstructured":"Heresi GA, Minai OA, Tonelli AR, Hammel JP, Farha S, Parambil JG, et al. Clinical characterization and survival of patients with borderline elevation in pulmonary artery pressure. Pulm Circ. 2013;3(4):916\u201325.","journal-title":"Pulm Circ"},{"issue":"4","key":"2552_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1164\/rccm.201706-1215OC","volume":"197","author":"P Douschan","year":"2018","unstructured":"Douschan P, Kovacs G, Avian A, Foris V, Gruber F, Olschewski A, et al. Mild elevation of pulmonary arterial pressure as a predictor of Mortality. Am J Respir Crit Care Med. 2018;197(4):509\u201316.","journal-title":"Am J Respir Crit Care Med"},{"issue":"13","key":"2552_CR20","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1161\/CIRCULATIONAHA.115.020207","volume":"133","author":"BA Maron","year":"2016","unstructured":"Maron BA, Hess E, Maddox TM, Opotowsky AR, Tedford RJ, Lahm T, et al. Association of Borderline Pulmonary Hypertension with Mortality and hospitalization in a large patient cohort: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. Circulation. 2016;133(13):1240\u20138.","journal-title":"Circulation"},{"issue":"12","key":"2552_CR21","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.healun.2022.09.005","volume":"41","author":"C Fauvel","year":"2022","unstructured":"Fauvel C, Raitiere O, Boucly A, De Groote P, Renard S, Bertona J, et al. Interest of TAPSE\/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment. J Heart Lung Transplant. 2022;41(12):1761\u201372.","journal-title":"J Heart Lung Transplant"},{"key":"2552_CR22","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.ijcard.2018.01.053","volume":"266","author":"K Tello","year":"2018","unstructured":"Tello K, Axmann J, Ghofrani HA, Naeije R, Narcin N, Rieth A, et al. Relevance of the TAPSE\/PASP ratio in pulmonary arterial hypertension. Int J Cardiol. 2018;266:229\u201335.","journal-title":"Int J Cardiol"},{"key":"2552_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.amjcard.2022.06.004","volume":"178","author":"M Ismayl","year":"2022","unstructured":"Ismayl M, Machanahalli Balakrishna A, Aboeata A, Gupta T, Young MN, Altin SE, et al. Meta-analysis comparing Catheter-Directed Thrombolysis Versus systemic anticoagulation alone for Submassive Pulmonary Embolism. Am J Cardiol. 2022;178:154\u201362.","journal-title":"Am J Cardiol"},{"issue":"7","key":"2552_CR24","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/08850666211036446","volume":"37","author":"JR Buckley","year":"2022","unstructured":"Buckley JR, Wible BC. In-Hospital mortality and related outcomes for elevated risk Acute Pulmonary Embolism treated with mechanical Thrombectomy Versus Routine Care. J Intensive Care Med. 2022;37(7):877\u201382.","journal-title":"J Intensive Care Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-023-02552-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-023-02552-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T15:26:42Z","timestamp":1700234802000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-023-02552-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,25]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2552"],"URL":"https:\/\/doi.org\/10.1186\/s12931-023-02552-w","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,25]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LL received speaker honoraria from AstraZeneca,\u00a0ReCor Medical and Medtronic. FG is supported by the German Foundation of Heart Research and has received speaker honoraria from Astra-Zeneca. SE received speaker honoraria and\/or travel support from Akcea Therapeutics, AstraZeneca, Bayer, Berlin Chemie, Bristol-Myers Squibb, Pfizer, B\u00f6hringer Ingelheim, Daiichi Sankyo, Edwards Lifesciences, Inari medical, Kaneka Pharma, Medtronic, Novartis and Recor. MB is supported by the Deutsche Forschungsgemeinschaft (German Research Foundation; TTR 219, project number 322900939) and reports personal fees from Abbott, Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Cytokinetics, Edwards, Medtronic, Novartis, Recor, Servier and Vifor during the conduct of the study. FM is supported by Deutsche Gesellschaft f\u00fcr Kardiologie (DGK), Deutsche Forschungsgemeinschaft (SFB TRR219), and Deutsche Herzstiftung. He has received scientific support from Ablative Solutions, Medtronic and ReCor Medical and speaker honoraria\/consulting fees from Ablative Solutions, Amgen, Astra-Zeneca, Bayer, Boehringer Ingelheim, Inari, Medtronic, Merck, ReCor Medical, Servier, and Terumo. PPN, HAG, BH, PL, SK, AL, and BS report no conflict of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The trial was approved by the local ethics committee (ethic committee of the \u00c4rztekammer des Saarlandes) and complied with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"257"}}